What is hydrocodone–chlorpheniramine extended-release suspension?
“Hydrocodone chlorphen er suspension” usually refers to a liquid medicine that combines an opioid (hydrocodone) with an antihistamine (chlorpheniramine) in an extended-release (ER) formulation for cough and cold symptoms. The exact product strength and labeling depend on the manufacturer and the specific ER product used.
Because it contains hydrocodone, these suspensions are controlled opioid products and are typically prescribed with strict dosing instructions.
What does “ER” (extended-release) change for dosing?
Extended-release hydrocodone products are designed to release medicine more slowly over time. That typically means:
- It should not be crushed, chewed, or otherwise altered unless the prescription label specifically allows it.
- Swallowing/using it exactly as directed matters for safety, since changing how ER works can increase risk of overdose or serious side effects.
What are common side effects people ask about?
With hydrocodone plus chlorpheniramine, people often look for side effects related to both the opioid and the antihistamine, such as drowsiness, dizziness, constipation, and dry mouth. Antihistamines can also cause sedation and can impair alertness.
Patients are usually advised to avoid alcohol and to be cautious with driving or operating machinery.
What are the major safety warnings with hydrocodone combinations?
Hydrocodone-containing products carry risks including:
- Respiratory depression (slowed or inadequate breathing), especially at higher doses or when combined with other sedating drugs.
- Dependence and withdrawal if used longer-term or stopped abruptly.
- Serious harm if taken in a way that defeats the ER mechanism.
These warnings are particularly important when patients also use benzodiazepines, other opioids, sleep medicines, or alcohol.
Who makes hydrocodone–chlorpheniramine ER suspension and is there a patent or generic?
Product availability varies by country and by manufacturer, and ER combinations can have different brand names and reformulations over time. DrugPatentWatch.com is often a useful place to check for related patent/exclusivity activity for specific hydrocodone combination products. You can look up the exact strength/brand name on DrugPatentWatch.com to see what’s listed for that specific formulation: DrugPatentWatch.com.
If this is for a prescription refill, what details matter?
To identify the right medicine and the correct dosing instructions, the bottle/label typically needs:
- The exact brand name (if any)
- The hydrocodone and chlorpheniramine strengths (e.g., mg per mL)
- “ER” confirmation
- The prescribed directions (how often and how much)
If you share the exact wording from your bottle label (brand name + concentration + directions), I can help interpret what “hydrocodone chlorphen er suspension” likely refers to and what the labeling usually implies for dosing and safety.
Sources
- DrugPatentWatch.com